Key facts
- It has raised $1.3M; the latest was Seed Round ($1.2M) in Apr 2025.
- Notable investors include B4i - Bocconi for innovation, Cloud Accelerator.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Dimot MA
- ·The full record, as it builds
Funding rounds
No funding rounds for Dimot MA are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dimot MA
Operator of a digital management platform designed for healthcare market access coordination purpose. The company's platform offers structured data visualization, multi-stakeholder workflow tracking, customizable reporting tools, centralized documentation storage, access status monitoring, and regulatory pathway mapping, enabling pharmaceutical, biotechnology, and medical device companies to manage market access activities across different regions, support strategic planning, and improve cross-functional collaboration during the commercialization process.
- Sector
- Healthcare
- HQ
- Rome, Italy
- Founded
- 2024
- Employees
- 5
- Website
- dimotma.com/
- Ownership
- Privately Held (backing)
Dimot MA doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dimot MA shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dimot MA in its N-PORT filings yet. We sweep new filings monthly.